German Jordanian University (GJU) in Amman is a public university in Jordan. Their practice-oriented teaching style is modelled after the German model of applied sciences. One-quarter of the GJU faculty come from Germany. During their five-year program, the students spend their fourth year in Germany. This year is divided so that the first semester is spent at a partner university, and the second semester is spent performing an internship at a German company.
CardioSecur supports GJU as a partner company. In addition to varied specialty areas for internships, we offer the best interns and students the possibility to write their bachelor thesis with us. Within the scope of their specialty, we support the students in independently carrying out research.
Helios.hub is the eHealth Accelerator of the HELIOS clinics. It supports entrepreneurs and startups to develop, test, and implement digital applications into clinical practice. HELIOS offers testing possibilities in over 100 clinics and a broad network encompassing other service providers, patient representatives, and experts from all fields.
CardioSecur is being implemented in the Helios Clinic in Wuppertal for patients with arrhythmias.
Dr. Reifart has been listed as one of the best cardiologists in Germany by Focus’ Physician List 2017. The Cardiac Institute of Professor Reifart & Partners has been in Bad Soden am Taunus and Hofheim am Taunus since 1997. They perform check-ups for prevention, diagnosis, and treatment of all diseases of the cardiovascular system. Additionally, their focus is on interventional cardiology and angiology for treatment of acute heart attacks and re-opening of coronary arteries that have been occluded for years.
The scientific study supported by CardioSecur in cooperation with Professor Reifart & Partners has the goal of evaluating the equivalency of a vector ECG with 4 electrodes (CardioSecur) and a standard ECG with 10 electrodes (Schiller AT-2) under stress. 14 electrodes are therefore attached to the patient’s chest: 10 for the standard ECG and 4 for the CardioSecur ECG.
The focus is on patients with known or presumed coronary artery disease (CAD). The study will provide a descriptive statement regarding various standard parameters of ECG analysis such as rhythm, rate, axis, and AV conduction. The primary objective is to examine the sensitivity of ST-segment changes 70 ms after the so-called J-point.
The study began in July 2017 and will include 500 subjects.
Study title: Comparison of a vector-generated ECG and the standard leads during a bicycle ergometer examination in patients with suspected stenosing CAD.
Lead investigator: Professor Dr. Nicolaus Reifart
Other examiners: Doctoral candidate Jörg Alexander Langanke and Jörg Reifart
Rhön-Klinikum is one of the largest healthcare providers in Germany, operating hospitals, clinics and group medical practices.
Rhön-Klinikum uses CardioSecur to monitor the success of ablation therapy in patients with arrhythmias.
The Staufenklinikum Schwäbisch Gmünd is a community hospital and has been a part of the Network of Ostalb Clinics since 2017. It is also the academic teaching hospital for the University of Ulm.
The Staufenklinikum is carrying out a comparison study between CardioSecur and the standard 12-lead ECG among neonates, toddlers, children, and teenagers.
Universitätsklinikum Heidelberg is one of the largest and most renowned medical centers within Germany. The medical school of the University of Heidelberg is among the leading European biomedical research institutes. It has existed since 1388, making it the oldest in Germany. The joint goal of the hospital and medical school is the development of innovative diagnostics and therapeutics, including their rapid implementation for patients.
The Uniklinik Heidelberg is using CardioSecur in ambulances and helicopters. This project has the title “4-Point (22-lead) ECG as an Alternative to the Classic 12-lead ECG in Emergency Medicine.”
The Universitätsklinikum Hamburg-Eppendorf (UKE) is one of the most modern hospitals within Europe. Highly specialized experts in numerous specialties work together under the same roof. The latest medical technologies, innovative information technology and care-oriented architecture support physicians, nurses, and therapists to foster close interaction between state of the art medicine, research, and teaching. More than 10,000 individuals are employed here to provide round-the-clock care for their patients.
CardioSecur supports the Hamburg City Health Study (HCHS). The HCHS is the largest location-based long-term study in the world. In the next few years, 45,000 Hamburg residents between 45 and 74 years of age will participate. The goal is to better understand the major widespread diseases heart attack, atrial fibrillation, stroke, and dementia, thereby making the city healthier.
The Center for Telemedicine in Bad Kissingen (ZTM) develops sustainable telemedicine networks in the sectors of emergency services, disaster control, hospitals and care facilities. Their goal is to offer the best possible medical care through new treatment methods and innovate medical products.
CardioSecur is one of the newest telemedicine products at ZTM and is regularly presented as a partner of the center.